OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protective effects of gemigliptin against type II collagen degradation in human chondrocytes
Momin Mohetaer, Guoqing Li, Yang Wang, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 104, pp. 590-594
Closed Access | Times Cited: 12

Showing 12 citing articles:

Association of Dipeptidylpeptidase 4 (CD26) With Chondrocyte Senescence and Radiographic Progression in Knee Osteoarthritis
Yu‐Hsiu Chen, Xin Zhang, Ching‐Heng Chou, et al.
Arthritis & Rheumatology (2023) Vol. 75, Iss. 7, pp. 1120-1131
Open Access | Times Cited: 19

Protective effect of vildagliptin on TNF‐α‐induced chondrocyte senescence
Jianping Bi, Wusheng Cai, Teng Ma, et al.
IUBMB Life (2019) Vol. 71, Iss. 7, pp. 978-985
Open Access | Times Cited: 32

Saxagliptin suppresses degradation of type II collagen and aggrecan in primary human chondrocytes: a therapeutic implication in osteoarthritis
Ning Hu, Xuan Gong, Shijie Yin, et al.
Artificial Cells Nanomedicine and Biotechnology (2019) Vol. 47, Iss. 1, pp. 3239-3245
Open Access | Times Cited: 26

Lixisenatide attenuates advanced glycation end products (AGEs)-induced degradation of extracellular matrix in human primary chondrocytes
Xin Li, Fangteng Jia, Zhengqing Zhu, et al.
Artificial Cells Nanomedicine and Biotechnology (2019) Vol. 47, Iss. 1, pp. 1256-1264
Open Access | Times Cited: 15

Zafirlukast attenuates advanced glycation end-products (AGEs)-induced degradation of articular extracellular matrix (ECM)
Changjiang Lei, Shixing Wu, Chong Wen, et al.
International Immunopharmacology (2019) Vol. 68, pp. 68-73
Closed Access | Times Cited: 14

<p>Lentinan Inhibits AGE-Induced Inflammation and the Expression of Matrix-Degrading Enzymes in Human Chondrocytes</p>
Zhaozhen Zhang, Zhuqing Zha, Zhiwei Zhao, et al.
Drug Design Development and Therapy (2020) Vol. Volume 14, pp. 2819-2829
Open Access | Times Cited: 11

The protective effects of exenatide against AGEs-induced articular matrix degradation in human primary chondrocytes.
Changgui Tong, Haidong Liang, Xuehui Liu, et al.
PubMed (2019) Vol. 11, Iss. 4, pp. 2081-2089
Closed Access | Times Cited: 9

Protective effects of alogliptin against TNF-α-induced degradation of extracellular matrix in human chondrocytes
Panpan Zhang, Yuhua Chen, Huafei Zhao, et al.
International Immunopharmacology (2019) Vol. 68, pp. 179-184
Closed Access | Times Cited: 6

Changes of type II collagenase biomarkers on IL‑1β‑induced rat articular chondrocytes
Xiangying Ma, Zhiheng Zhang, Meilun Shen, et al.
Experimental and Therapeutic Medicine (2021) Vol. 21, Iss. 6
Open Access | Times Cited: 6

Teneligliptin inhibits IL‐1β‐induced degradation of extracellular matrix in human chondrocytes
Feng Gao, Yanbing Wang, Minfei Wu
Journal of Cellular Biochemistry (2020) Vol. 121, Iss. 11, pp. 4450-4457
Closed Access | Times Cited: 5

Reply
Yu‐Hsiu Chen, Xin Zhang, Virginia B. Kraus
Arthritis & Rheumatology (2023) Vol. 75, Iss. 9, pp. 1679-1680
Open Access

Page 1

Scroll to top